Thyroid Eye Disease (TED) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034
Thyroid Eye Disease (TED) Market Outlook Thelansis’s “Thyroid Eye Disease (TED) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Thyroid Eye Disease (TED) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Thyroid Eye Disease (TED) Overview Thyroid eye disease (TED) is a rare, debilitating autoimmune disease known as Graves’ orbitopathy or thyroid-associated ophthalmopathy. After 1 to 3 years, the disease progresses from an active progressive period marked by inflammation to a stable and fibrotic period. It affects approximately 40% of Graves’ disease patients. In Graves’ disease, autoantibodies (thyroid-stimulating immuno...